open access

Vol 17, No 2 (2010)
Case Reports
Submitted: 2013-01-14
Published online: 2010-03-29
Get Citation

Myocardial infarction in a low risk patient with hereditary hemorrhagic telangiectasia

Marianna Janion, Halina Brzyzkiewicz, Marcin Siuda, Szymon Domagała, Michał Karliński
Cardiol J 2010;17(2):189-191.

open access

Vol 17, No 2 (2010)
Case Reports
Submitted: 2013-01-14
Published online: 2010-03-29

Abstract

We describe the case of a 57 year-old woman with NSTE ACS, a history of recurrent and prolonged epistaxis, and low prior cardiovascular risk. Additional findings revealed anemia and an aneurysm in her central nervous system. During her hospital stay, hereditary hemorrhagic telangiectasia (HHT) was diagnosed. After application of two antiplatelet drugs, the patient was scheduled for coronarography, followed by coronary artery bypass grafting. During her hospital stay, only a minor episode of epistaxis was observed. We conclude that anemization due to HTT may significantly accelerate the progress of ischemic heart disease, resulting in acute coronary syndrome. Moreover, coronarography preceded by routine application of two antiplatelet drugs seems not to increase the risk of hemorrhage in HHT patients complicated with myocardial infarction.
(Cardiol J 2010; 17, 2: 189-191)

Abstract

We describe the case of a 57 year-old woman with NSTE ACS, a history of recurrent and prolonged epistaxis, and low prior cardiovascular risk. Additional findings revealed anemia and an aneurysm in her central nervous system. During her hospital stay, hereditary hemorrhagic telangiectasia (HHT) was diagnosed. After application of two antiplatelet drugs, the patient was scheduled for coronarography, followed by coronary artery bypass grafting. During her hospital stay, only a minor episode of epistaxis was observed. We conclude that anemization due to HTT may significantly accelerate the progress of ischemic heart disease, resulting in acute coronary syndrome. Moreover, coronarography preceded by routine application of two antiplatelet drugs seems not to increase the risk of hemorrhage in HHT patients complicated with myocardial infarction.
(Cardiol J 2010; 17, 2: 189-191)
Get Citation

Keywords

acute coronary syndrome; hereditary hemorrhagic telangiectasia; anemia

About this article
Title

Myocardial infarction in a low risk patient with hereditary hemorrhagic telangiectasia

Journal

Cardiology Journal

Issue

Vol 17, No 2 (2010)

Pages

189-191

Published online

2010-03-29

Page views

582

Article views/downloads

1254

Bibliographic record

Cardiol J 2010;17(2):189-191.

Keywords

acute coronary syndrome
hereditary hemorrhagic telangiectasia
anemia

Authors

Marianna Janion
Halina Brzyzkiewicz
Marcin Siuda
Szymon Domagała
Michał Karliński

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., Grupa Via Medica, ul. Świętokrzyska 73, 80–180 Gdańsk, Poland
tel.:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl